Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Mise à jour : Il y a 4 ans
Référence : NCT00419094

Femme et Homme

Extrait

The primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial onset seizures.


Critère d'inclusion

  • Epilepsy


Liens